Respected sir, iam suffer from diabeteic about 1 year,my LFT show alt value 22.39 , ast value 23.45 platelets 150000 mpv 52 lipid parameter total colestsral 245 ldl 197 tg182 non hdl210, fib 4 score1.67 recently consult hepatogist at Aig hospital Hyderabad he tested fibroscan test my lsm value 4.5 cap score295. My dr precribe Metfor 500 , rusuvastatin 5 mg , bilypsa 4mg for daily, with life style change . Sir I continue bilypsa for low platelets it is saftey and effective, how much time I use long run it is useful please suggest continue thease medicines or change and add another medicine.
I would suggest you to continue treatment as recommended by your treating doctor. Regarding bylipsa, I.e. saroglitazar molecule, it has been studied in non-alcoholic fatty liver disease and it is approved in India for NAFLD. Studies have shown its safety and efficacy and it can be continued for at least 1 year. Follow the treatment of your doctor and most important is adopting healthy lifestyle and managing body weight.
Saroglitazar would also help in controlling your abnormal lipids, in particularly hight TG and non hdl values along with insulin resistance of type 2 diabetes.
Sir plz make more and more video like this
Superb sir
Thank you sir
Respected sir, iam suffer from diabeteic about 1 year,my LFT show alt value 22.39 , ast value 23.45 platelets 150000 mpv 52 lipid parameter total colestsral 245 ldl 197 tg182 non hdl210, fib 4 score1.67 recently consult hepatogist at Aig hospital Hyderabad he tested fibroscan test my lsm value 4.5 cap score295. My dr precribe Metfor 500 , rusuvastatin 5 mg , bilypsa 4mg for daily, with life style change . Sir I continue bilypsa for low platelets it is saftey and effective, how much time I use long run it is useful please suggest continue thease medicines or change and add another medicine.
I would suggest you to continue treatment as recommended by your treating doctor. Regarding bylipsa, I.e. saroglitazar molecule, it has been studied in non-alcoholic fatty liver disease and it is approved in India for NAFLD. Studies have shown its safety and efficacy and it can be continued for at least 1 year. Follow the treatment of your doctor and most important is adopting healthy lifestyle and managing body weight.
Saroglitazar would also help in controlling your abnormal lipids, in particularly hight TG and non hdl values along with insulin resistance of type 2 diabetes.
Thank you sir